MX346332B - Cepas probioticas para aumentar la resistencia transepitelial. - Google Patents
Cepas probioticas para aumentar la resistencia transepitelial.Info
- Publication number
- MX346332B MX346332B MX2012013835A MX2012013835A MX346332B MX 346332 B MX346332 B MX 346332B MX 2012013835 A MX2012013835 A MX 2012013835A MX 2012013835 A MX2012013835 A MX 2012013835A MX 346332 B MX346332 B MX 346332B
- Authority
- MX
- Mexico
- Prior art keywords
- transepithelial resistance
- probiotic strains
- improving
- improving transepithelial
- resistance
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente invención se refiere a una composición que comprende al menos una cepa bacteriana seleccionada del grupo que consiste en lactobacilos y bifidobacterias para usarse en el incremento de la Resistencia Eléctrica Transepitelial (TEER, por sus siglas en inglés) de las células epiteliales intestinales, en conde dicha cepa se selecciona del grupo que consiste en DN_116_0044 (CNCMI-4316 presentada el 19 de mayo de 2019) y DN_154_0062 (CNCMI-4319 presentada 19 de mayo de 2010).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2010/001536 WO2011148220A1 (en) | 2010-05-28 | 2010-05-28 | Probiotic strains for use in improving transepithelial resistance |
PCT/IB2011/052368 WO2011148358A1 (en) | 2010-05-28 | 2011-05-30 | Probiotic strains for use in improving transepithelial resistance |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012013835A MX2012013835A (es) | 2013-04-08 |
MX346332B true MX346332B (es) | 2017-03-15 |
Family
ID=43334416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012013835A MX346332B (es) | 2010-05-28 | 2011-05-30 | Cepas probioticas para aumentar la resistencia transepitelial. |
Country Status (14)
Country | Link |
---|---|
US (1) | US9402872B2 (es) |
EP (1) | EP2575834B1 (es) |
JP (1) | JP5816273B2 (es) |
KR (1) | KR101790683B1 (es) |
CN (1) | CN103079581B (es) |
BR (1) | BR112012030363A2 (es) |
CA (1) | CA2800770C (es) |
EA (1) | EA024443B1 (es) |
ES (1) | ES2514326T3 (es) |
MX (1) | MX346332B (es) |
PL (1) | PL2575834T3 (es) |
PT (1) | PT2575834E (es) |
WO (2) | WO2011148220A1 (es) |
ZA (1) | ZA201208978B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011148219A1 (en) * | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving the enteric nervous system |
PL2794930T3 (pl) * | 2011-12-21 | 2017-03-31 | Compagnie Gervais Danone | Nowy szczep lactobacillus mucosae |
WO2014096901A1 (en) | 2012-12-18 | 2014-06-26 | Compagnie Gervais Danone | Strain of bifidobacterium animalis ssp. animalis |
EP3319615A1 (en) * | 2015-07-10 | 2018-05-16 | DSM IP Assets B.V. | Food and/or feed compositions for preventing and treating inflammatory diseases |
WO2023118510A1 (en) | 2021-12-22 | 2023-06-29 | N.V. Nutricia | Mix of specific bifidobacterium species and specific non-digestible oligosaccharides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1119154C (zh) * | 1998-01-20 | 2003-08-27 | 上海信谊药业有限公司 | 双歧三联活菌制剂及制备方法 |
US20030092163A1 (en) | 2001-07-26 | 2003-05-15 | Collins John Kevin | Probiotic bifidobacterium strains |
US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
WO2006122850A1 (en) * | 2005-05-16 | 2006-11-23 | Universite De Liege | Probiotic bifidobacterial species |
DK2277524T3 (en) | 2005-09-28 | 2016-02-08 | Nordisk Rebalance As | Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors |
PL1981516T3 (pl) * | 2006-01-27 | 2019-03-29 | Dupont Nutrition Biosciences Aps | Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom |
PL2072053T3 (pl) | 2007-12-21 | 2013-02-28 | Gervais Danone Sa | Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium |
WO2009158384A1 (en) * | 2008-06-27 | 2009-12-30 | The Procter & Gamble Company | Methods and kits for the treatment inhibition, and maintenance of gastrointestinal disorders |
-
2010
- 2010-05-28 WO PCT/IB2010/001536 patent/WO2011148220A1/en active Application Filing
-
2011
- 2011-05-30 JP JP2013511784A patent/JP5816273B2/ja active Active
- 2011-05-30 EP EP11727794.7A patent/EP2575834B1/en active Active
- 2011-05-30 EA EA201291440A patent/EA024443B1/ru not_active IP Right Cessation
- 2011-05-30 PL PL11727794T patent/PL2575834T3/pl unknown
- 2011-05-30 PT PT117277947T patent/PT2575834E/pt unknown
- 2011-05-30 BR BR112012030363A patent/BR112012030363A2/pt not_active Application Discontinuation
- 2011-05-30 CN CN201180026423.5A patent/CN103079581B/zh active Active
- 2011-05-30 WO PCT/IB2011/052368 patent/WO2011148358A1/en active Application Filing
- 2011-05-30 MX MX2012013835A patent/MX346332B/es active IP Right Grant
- 2011-05-30 CA CA2800770A patent/CA2800770C/en active Active
- 2011-05-30 KR KR1020127034390A patent/KR101790683B1/ko active IP Right Grant
- 2011-05-30 ES ES11727794.7T patent/ES2514326T3/es active Active
- 2011-05-30 US US13/700,482 patent/US9402872B2/en active Active
-
2012
- 2012-11-28 ZA ZA2012/08978A patent/ZA201208978B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2012013835A (es) | 2013-04-08 |
BR112012030363A2 (pt) | 2016-08-09 |
EP2575834A1 (en) | 2013-04-10 |
CA2800770A1 (en) | 2011-12-01 |
JP5816273B2 (ja) | 2015-11-18 |
ZA201208978B (en) | 2014-04-30 |
EP2575834B1 (en) | 2014-06-25 |
PT2575834E (pt) | 2014-10-01 |
US9402872B2 (en) | 2016-08-02 |
PL2575834T3 (pl) | 2015-03-31 |
CA2800770C (en) | 2019-09-10 |
KR101790683B1 (ko) | 2017-10-26 |
CN103079581A (zh) | 2013-05-01 |
KR20130141350A (ko) | 2013-12-26 |
JP2013527194A (ja) | 2013-06-27 |
EA024443B1 (ru) | 2016-09-30 |
US20130216510A1 (en) | 2013-08-22 |
CN103079581B (zh) | 2015-08-05 |
WO2011148220A1 (en) | 2011-12-01 |
EA201291440A1 (ru) | 2013-04-30 |
ES2514326T3 (es) | 2014-10-28 |
WO2011148358A1 (en) | 2011-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012013834A (es) | Cepas probioticas para mejorar el sistema nervioso enterico. | |
IN2012DN01638A (es) | ||
IN2012DN02463A (es) | ||
GB2480042A (en) | Prebiotic formulations and methods of use | |
IN2012DN02737A (es) | ||
UA108198C2 (uk) | Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування | |
WO2012112777A3 (en) | Biosynthesis of human milk oligosaccharides in engineered bacteria | |
MX2011005527A (es) | Uso de la bacteria de acido lactico para tratar o prevenir el eczema. | |
BR112012033212A2 (pt) | uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica | |
MX2015006491A (es) | Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas. | |
GB2482536B (en) | Expression of antibody or a fragment thereof in lactobacillus | |
WO2011110918A8 (en) | Composition comprising probiotic bacteria for use in the treatment of immune disorders | |
MX2011011670A (es) | Inmunoglobulinas de dominio variable dual y usos de las mismas. | |
PL2753687T3 (pl) | Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium | |
GB2511993A (en) | Prebiotic formulations and methods of use | |
IN2012DN00624A (es) | ||
MX2011008398A (es) | Lactobacillus helveticus cncm i-4095 y el control del peso. | |
MY158310A (en) | Prevention and treatment of allergic diarrhoea | |
MX2011008400A (es) | Lactobacillus rhamnosus cncm i-4096 y el control del peso. | |
MX2012013835A (es) | Cepas probioticas para aumentar la resistencia transepitelial. | |
WO2012019054A3 (en) | Expression of antibody or a fragment thereof in lactobacillus | |
HK1173182A1 (en) | Proliferation-enhancing agent and or survivability-improving agent for lactic acid bacterium belonging to genus lactobacillus | |
MX2012007970A (es) | Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico. | |
IN2014DN08385A (es) | ||
GEP20207089B (en) | Histamine-producing bacterial strains and their use in cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |